Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,035 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB-IVM1c melanoma.
Chesney J, Awasthi S, Curti B, Hutchins L, Linette G, Triozzi P, Tan MCB, Brown RE, Nemunaitis J, Whitman E, Windham C, Lutzky J, Downey GF, Batty N, Amatruda T. Chesney J, et al. Among authors: awasthi s. Melanoma Res. 2018 Feb;28(1):44-51. doi: 10.1097/CMR.0000000000000399. Melanoma Res. 2018. PMID: 29176501 Clinical Trial.
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
Tarhini AA, Frankel P, Ruel C, Ernstoff MS, Kuzel TM, Logan TF, Khushalani NI, Tawbi HA, Margolin KA, Awasthi S, Butterfield LH, McDermott D, Chen A, Lara PN, Kirkwood JM. Tarhini AA, et al. Among authors: awasthi s. Cancer. 2018 Nov 15;124(22):4332-4341. doi: 10.1002/cncr.31734. Epub 2018 Oct 10. Cancer. 2018. PMID: 30303516 Free PMC article. Clinical Trial.
Notch signaling in breast cancer: From pathway analysis to therapy.
Krishna BM, Jana S, Singhal J, Horne D, Awasthi S, Salgia R, Singhal SS. Krishna BM, et al. Among authors: awasthi s. Cancer Lett. 2019 Oct 1;461:123-131. doi: 10.1016/j.canlet.2019.07.012. Epub 2019 Jul 18. Cancer Lett. 2019. PMID: 31326555 Free PMC article. Review.
Targeting the mercapturic acid pathway for the treatment of melanoma.
Singhal SS, Srivastava S, Mirzapoiazova T, Horne D, Awasthi S, Salgia R. Singhal SS, et al. Among authors: awasthi s. Cancer Lett. 2021 Oct 10;518:10-22. doi: 10.1016/j.canlet.2021.06.004. Epub 2021 Jun 11. Cancer Lett. 2021. PMID: 34126193 Review.
RLIP inhibition suppresses breast-to-lung metastasis.
Singhal J, Chikara S, Horne D, Salgia R, Awasthi S, Singhal SS. Singhal J, et al. Among authors: awasthi s. Cancer Lett. 2019 Apr 10;447:24-32. doi: 10.1016/j.canlet.2019.01.023. Epub 2019 Jan 23. Cancer Lett. 2019. PMID: 30684594 Free PMC article.
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer.
Fleming MT, Sonpavde G, Kolodziej M, Awasthi S, Hutson TE, Martincic D, Rastogi A, Rousey SR, Weinstein RE, Galsky MD, Berry WR, Wang Y, Boehm KA, Asmar L, Rauch MA, Beer TM. Fleming MT, et al. Among authors: awasthi s. Clin Genitourin Cancer. 2012 Mar;10(1):6-14. doi: 10.1016/j.clgc.2011.11.003. Clin Genitourin Cancer. 2012. PMID: 22340631 Clinical Trial.
1,035 results